Salmonella serovars parE conferring resistance to fluoroquinolones

Accession ARO:3003317
CARD Short NameSser_parE_FLO
DefinitionPoint mutation in Salmonella serovars parE resulting in fluoroquinolones resistance.
AMR Gene Familyfluoroquinolone resistant parE
Drug Classfluoroquinolone antibiotic
Resistance Mechanismantibiotic target alteration
Resistomes with Sequence VariantsEscherichia coliwgs
Classification11 ontology terms | Show
Parent Term(s)14 ontology terms | Show
+ fluoroquinolone resistant parE [AMR Gene Family]
+ confers_resistance_to_antibiotic ciprofloxacin [Antibiotic]
+ confers_resistance_to_antibiotic enoxacin [Antibiotic]
+ confers_resistance_to_antibiotic gatifloxacin [Antibiotic]
+ confers_resistance_to_antibiotic grepafloxacin [Antibiotic]
+ confers_resistance_to_antibiotic levofloxacin [Antibiotic]
+ confers_resistance_to_antibiotic lomefloxacin [Antibiotic]
+ confers_resistance_to_antibiotic moxifloxacin [Antibiotic]
+ confers_resistance_to_antibiotic nalidixic acid [Antibiotic]
+ confers_resistance_to_antibiotic norfloxacin [Antibiotic]
+ confers_resistance_to_antibiotic ofloxacin [Antibiotic]
+ confers_resistance_to_antibiotic pefloxacin [Antibiotic]
+ confers_resistance_to_antibiotic sparfloxacin [Antibiotic]
+ confers_resistance_to_antibiotic trovafloxacin [Antibiotic]
Publications

O'Regan E, et al. 2009. Antimicrob Agents Chemother 53(3): 1080-1087. Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators. (PMID 19104017)

Resistomes

Prevalence of Salmonella serovars parE conferring resistance to fluoroquinolones among the sequenced genomes, plasmids, and whole-genome shotgun assemblies available at NCBI or IslandViewer for 413 important pathogens (see methodological details and complete list of analyzed pathogens). Values reflect percentage of genomes, plasmids, genome islands, or whole-genome shotgun assemblies that have at least one hit to the AMR detection model. Default view includes percentages calculated based on Perfect plus Strict RGI hits. Select the checkbox to view percentages based on only Perfect matches to AMR reference sequences curated in CARD (note: this excludes resistance via mutation as references in protein variant models are often wild-type, sensitive sequences).

Prevalence: protein variant model (view sequences)

SpeciesNCBI ChromosomeNCBI PlasmidNCBI WGSNCBI GI
Escherichia coli0%0%0.01%0%
Show Perfect Only


Detection Models

Model Type: protein variant model

Model Definition: Protein Variant Models (PVM) perform a similar search as Protein Homolog Models (PHM), i.e. detect protein sequences based on their similarity to a curated reference sequence, but secondarily screen query sequences for curated sets of mutations to differentiate them from antibiotic susceptible wild-type alleles. PVMs are designed to detect AMR acquired via mutation of house-keeping genes or antibiotic targets, e.g. a mutated gyrase resistant to aminocoumarin antibiotics. PVMs include a protein reference sequence (often from antibiotic susceptible wild-type alleles), a curated bit-score cut-off, and mapped resistance variants. Mapped resistance variants may include any or all of single point mutations, insertions, or deletions curated from the scientific literature. A Strict RGI match has a BLASTP bit-score above the curated BLASTP cutoff value and contains at least one curated mutation from amongst the mapped resistance variants, while a Loose RGI match has a bit-score less than the curated BLASTP bit-score cut-off but still contains at least one curated mutation from amongst the mapped resistance variants.

Bit-score Cut-off (blastP): 1000

Legend:

  • discovered in clinical, agricultural, or environmental isolates

  • discovered via laboratory selection experiments

  • ReSeqTB https://platform.reseqtb.org

Published Variants:


>gb|AAL22055.1|-|Salmonella serovars parE conferring resistance to fluoroquinolones [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2]
MTQTYNADAIEVLTGLEPVRRRPGMYTDTTRPNHLGQEVIDNSVDEALAGHAKRVDVILH
ADQSLEVIDDGRGMPVDIHPEEGVPAVELILCRLHAGGKFSNKNYQFSGGLHGVGISVVN
ALSKRVEVTVRRDGQVYNIAFENGEKVQDLQVVGTCGKRNTGTSVHFWPDESFFDSPRFS
VSRLMHVLKAKAVLCPGVEITFKDEVNNSEQRWCYQDGLNDYLGEAVNGLPTLPEKPFIG
NFNGETEAVDWALLWLPEGGELLTESYVNLIPTMQGGTHVNGLRQGLLDAMREFCEYRNI
LPRGVKLSAEDIWDRCAYVLSVKMQDPQFAGQTKERLSSRQCAAFVSGVVKDAFSLWLNQ
NVQAAEQLAEMAIASAQRRLRAAKKVVRKKLTSGPALPGKLADCTAQDLNRTELFLVEGD
SAGGSAKQARDREYQAIMPLKGKILNTWEVSSDEVLASQEVHDISVAIGIDPDSDDLSQL
RYGKICILADADSDGLHIATLLCALFVRHFRALVKNGHVYVALPPLYRIDLGKEVYYALT
EEEKAGVLEQLKRKKGKPNVQRFKGLGEMNPMQLRETTLDPNTRRLVQLTISDEDDQRTN
AMMDMLLAKKRSEDRRNWLQEKGDLADLDV



>gb|AE006468.2|-|3343969-3345861|Salmonella serovars parE conferring resistance to fluoroquinolones [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2]
ATGACGCAAACTTATAACGCTGATGCCATTGAGGTACTCACTGGGCTTGAGCCGGTACGCCGCCGCCCGGGGATGTACACCGATACGACC
CGCCCCAACCATTTGGGTCAGGAAGTGATTGATAATAGTGTGGATGAAGCACTGGCAGGTCACGCCAAACGCGTGGATGTCATTTTACAT
GCCGATCAATCGCTGGAAGTGATTGACGACGGACGCGGGATGCCGGTGGATATCCATCCGGAAGAGGGGGTTCCGGCGGTAGAACTGATC
CTCTGTCGGCTTCATGCCGGCGGTAAATTCTCCAATAAGAACTATCAGTTCTCTGGTGGTCTGCATGGGGTGGGGATTTCGGTAGTAAAT
GCCCTGTCAAAGCGCGTGGAAGTGACCGTGCGCCGCGACGGTCAGGTCTATAACATCGCGTTTGAAAACGGCGAAAAAGTGCAGGATTTG
CAGGTTGTCGGCACCTGCGGTAAACGTAATACTGGAACCAGCGTCCATTTCTGGCCGGACGAAAGTTTCTTCGACAGCCCGCGTTTTTCT
GTCTCTCGCTTAATGCACGTTCTGAAAGCAAAAGCGGTGCTGTGTCCCGGCGTGGAAATCACTTTTAAAGATGAAGTGAATAACAGCGAG
CAGCGCTGGTGCTACCAGGATGGTCTGAACGACTATCTGGGCGAAGCGGTAAACGGCCTGCCGACGCTGCCGGAAAAGCCGTTTATCGGT
AATTTTAACGGTGAAACGGAAGCGGTTGACTGGGCGCTATTGTGGCTGCCGGAAGGCGGCGAATTACTGACGGAAAGCTACGTCAACCTG
ATCCCGACCATGCAGGGGGGGACGCACGTCAACGGTCTGCGCCAGGGCCTGCTCGACGCGATGCGCGAATTTTGCGAATACCGCAATATT
CTGCCGCGCGGCGTCAAACTGTCGGCGGAAGATATCTGGGATCGCTGCGCTTATGTGCTTTCCGTGAAAATGCAGGACCCGCAATTTGCC
GGGCAGACCAAAGAGCGTCTGTCGTCGCGTCAATGTGCGGCATTTGTTTCCGGCGTGGTGAAAGATGCCTTCAGCCTGTGGCTGAACCAG
AACGTGCAGGCGGCGGAACAACTGGCAGAGATGGCGATTGCCAGCGCGCAGCGGCGACTGCGCGCCGCAAAAAAAGTGGTGCGCAAAAAG
CTCACCAGCGGCCCGGCGTTGCCGGGGAAACTGGCGGACTGTACCGCGCAGGATCTTAATCGGACCGAGCTGTTCCTTGTGGAAGGGGAT
TCGGCGGGCGGTTCCGCCAAGCAGGCGCGCGATCGCGAATATCAGGCGATCATGCCGCTCAAAGGTAAGATCCTTAACACCTGGGAGGTC
TCTTCCGATGAAGTGCTGGCCTCGCAAGAAGTGCATGATATTTCCGTGGCGATCGGTATCGATCCGGACAGCGACGATCTGAGTCAGCTG
CGCTACGGCAAGATCTGTATCCTGGCGGATGCGGACTCCGATGGTTTGCATATCGCTACTCTGCTTTGCGCGCTGTTTGTCAGACACTTC
CGCGCGCTGGTGAAGAATGGTCATGTCTACGTCGCGCTACCGCCGCTATACCGTATCGATTTGGGTAAAGAGGTCTATTACGCGCTGACG
GAAGAAGAGAAGGCGGGCGTACTGGAACAACTGAAGCGTAAGAAAGGCAAGCCGAACGTACAGCGTTTCAAAGGCCTGGGAGAAATGAAC
CCGATGCAGTTACGCGAAACCACGCTTGATCCGAATACTCGCCGCCTGGTGCAGCTCACCATTAGCGATGAAGACGATCAGCGTACTAAT
GCGATGATGGATATGCTGCTGGCGAAGAAACGTTCTGAAGATCGACGCAACTGGCTACAGGAAAAAGGCGATCTCGCGGATCTCGACGTG
TAA